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doi:10.1016/j.kjms.2011.06.023Abstract The development of an instrument to estimate the incidence, characteristics, and
risk factors of benzodiazepine (BZD) dependence broadly in Taiwan is an important task. This
study assessed the validity of the Chinese version of the Severity of Dependence Scale (SDS[Ch])
among regular BZD users in Taiwan (nZ 228). A positive correlation was shown between SDS[Ch]
and Mini-International Neuropsychiatric Interview diagnosed of BZD dependence. Thirty-six
percent of the users received a Mini-International Neuropsychiatric Interview diagnosis of
current BZD dependence. The dependent users tended to be divorced/widowed; not schizo-
phrenic; and have higher SDS[Ch] scores, a longer duration of use, and multiple-BZD use. The
SDS[Ch] for BZD dependence was shown to have high diagnostic utility (area under the receiver
operating characteristic curveZ 0.779), a sensitivity of 80.5%, and a specificity of 85.7%, with
a cutoff point of 7. The findings support that the SDS[Ch] is a valid brief self-reported question-
naire for the assessment of BZD dependence among chronic users in Taiwan.
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Up to 40% of the general population annually suffers from
insomnia that causes significant morbidity, mortality, and
public health concern [1e5]. Although benzodiazepine
(BZD) hypnotics are proven to be among the fastest, safest,
most effective, and widely prescribed medications for
insomnia, the issue of BZD dependence is still a concern for
prescribing physicians and patients [2,6,7]. This BZD
dependence exists with physical and psychological depen-
dence. Physical dependence is a natural physiological
adaptation for pharmacological tolerance and withdrawal
symptoms or rebound phenomenon on rapid dose reduction
or discontinuation of BZD use. Psychological dependence is
a behavioral psychological adaptation for loss of self-
confidence, overreliance on the need for BZD, and varying
degrees of drug-seeking behavior. Among chronic BZD users,
psychological dependence is more relevant than physical
dependence [8e11]. The incidence of BZD dependence
among chronic users has been estimated to range from 15%
to 44% [12e15]; however, no statistics are yet available for
Taiwan.
BZD dependence and BZD-related problems result in an
array of negative health consequences and produce an
increased public health burden in Taiwan [16]; however,
few instruments have been developed to assess these
problems. The Severity of Dependence Scale (SDS) is a self-
administered, five-item questionnaire that measures the
degree of psychological dependence on different types of
illicit drugs. It is easy to understand and can be completed
by most users in less than 1 minute [9,17e19]. The SDS,
originally designed in English [17], was first used to screen
for BZD dependence among regular users [18]. The scale
was subsequently translated into many languages [20] and
put into widespread use for different illicit drugs across
different cultures.
The Chinese version of the SDS (SDS[Ch]) was developed
to measure the severity of dependence on heroin among
Taiwanese (Chinese) users [21], but it has not been vali-
dated on BZD users. This scale should be easy to use and
provide a broader assessment of BZD dependence among
chronic users in Taiwan. The present study explored the
validity of the SDS[Ch] when used to measure the severity of
BZD dependence among chronic users as part of a broader
research project to estimate the incidence, characteristics,




The eligible individuals were 228 outpatients who visited the
psychiatric departments of Kaohsiung Medical University
Hospital or Kaohsiung Municipal Hsiao-Kang Hospital from
January 2009 to December 2009. All had been prescribed BZD
hypnotics, including zolpidem (Stilnox), for 3 months or
longer. Other eligibility criteria included age greater than 18
years and a stable maintenance dosage of the BZD hypnotics
at the time of entry into the study. Patients with a current
diagnosis of dementia, mental retardation, organic brainsyndrome, history (in the past 12 months) of alcohol or other
substance dependence, acute or unstable psychotic or
physical disorders, and/or any problem that could interfere
with understanding this test were excluded. The study
protocol was approved by our Institutional Ethics
Committee, and all eligible patients gave their written
informed consent.
Measures
All eligible patients completed the SDS[Ch] and were asked to
give a global rating of their addiction to or dependence on
BZDs. The patients self-reported their level of dependence
using a 4-point scale (0, never/almost never; 1, sometimes; 2,
often; 3, always/nearly always for Items 1e4). The substance
use section of the Mini-International Neuropsychiatric Inter-
view (MINI) used to assess mental disorders according to the
definitions and criteria ofDiagnostic andStatisticalManual of
Mental DisordersdFourth Edition (American Psychiatric
Association, 1994) [22] was administered to each patient by
a senior psychiatrist who was blind to the SDS[Ch] results. A
current diagnosis of BZD dependence was given if three or
more symptoms had occurred in the last year. The reliability
and validity of MINI has been established. Other data for the
eligible individuals, including demographic characteristics
and daily dosage of BZD, were also collected.
Statistical analysis
The MINI was used to classify these patients into BZD-
dependent and non-BZD-dependent groups. The receiver
operating characteristic (ROC) curve was then used to
identify the cut-off point on the total score (0e15) of the
SDS[Ch]. The ROC curve is a plot of sensitivity against
(1 specificity) for a screening test, where the different
points on the curve correspond to different cutoff points
used to designate a positive test. The area under the ROC
curve (AUC) is a reasonable summary of the overall diag-
nostic accuracy of the test. In general, for two screening
tests for the same disease, the test with the higher AUC is
considered the better test, unless some particular level of
sensitivity or specificity is especially important in comparing
the two tests. The cutoff point was determined by choosing
the point on the ROC curve closest to the point of (0, 1). The
logistic regression was also estimated for the odds ratios of
BZD dependence, which adjusted for significant factors
identified in Table 1. Statistical analysis was performed using
SSPS version 14.0 (SPSS Inc., Chicago, IL, USA). All statistical
tests were two tailed, and p values less than 0.05 were
considered significant.
Results
Thirty-six percent of the 228 patients received a MINI
diagnosis of current BZD dependence. These BZD-depen-
dent patients tended to be divorced/widowed (pZ 0.032)
as well as to have diagnoses other than schizophrenia
(pZ 0.008), higher SDS[Ch] scores (p< 0.001), a longer
duration of use (pZ 0.022), and use of multiple BZDs
(p< 0.001). Age, gender, education level, employment,
and other habits (smoking cigarettes, chewing betel quid,
Table 1 Demographic characteristics of BZD-dependent and non-BZD-dependent users
Characteristic BZD-dependent users (nZ 82) Non-BZD-dependent users (nZ 146) p
Age (y) 43.9 10.7 45.7 11.3 0.397
Gender, n 0.163
Men/women 29/53 66/80
Education level (y) 13.5 2.6 13.4 2.8 0.791
Employment, n 0.104
Job/jobless 52/24 106/29
Marital status, n (%) 0.032
Single 18 (22.0) 38 (26.0)
Married 39 (47.6) 85 (58.2)
Divorced/widowed 25 (30.5) 23 (15.8)
Co-diagnosis, n (%) 0.008
Schizophrenia 7 (8.8) 31 (21.8)
Affective disorders 41 (51.3) 47 (33.1)
Others 32 (40.0) 64 (45.1)
Cigarette smoking habit, n 0.173
Never/ever/current 86/3/33 100/4/42
Alcohol drinking habit, n 0.180
Never/ever/current 56/18/8 112/28/6
Betel chewing habit, n 0.051
Never/ever/current 68/5/6 138/4/3
Coffee drinking habit, n 0.713
Never/ever/current 46/15/16 76/29/35
Tea drinking habit, n 0.413
Never/ever/current 32/12/33 50/32/58
SDS[Ch] score 8.8 2.8 5.6 3.2 <0.001
BZD use
Duration (mo) 54.2 44.0 74.6 67.3 0.022
Types, n 1.7 0.6 1.3 0.5 <0.001
BZDZ benzodiazepine; SDS[Ch]Z Chinese version of the Severity of Dependence Scale.
SDS[Ch] for BZD dependence in Taiwan 227drinking coffee or tea) were not significantly associated
with the incidence of BZD dependence. The demographic
characteristics of BZD-dependent and non-BZD-dependent
users in Taiwan are compared in Table 1.
For SDS[Ch] scores, the outcome values ranged from 0 to
15. The cutoff point was determined by computing the
corresponding sensitivity (1 specificity) and choosing the
point where sensitivity and 1 specificity were closest to
(0, 1). As shown in Table 2, a value of 7 showed the smallest
distance; therefore, for this screening test, if a patient
scored 7 or higher on these five questions, then he or she
could be classified as a BZD-dependent user. A cutoff point
of 7 or higher on the SDS[Ch] was shown to have high diag-
nostic utility (AUCZ 0.779), a sensitivity of 80.5%, and
a specificity of 85.7% in identifying problematic BZD users.
For SDS[Ch] Question 4 “Did you wish you could stop?” the
scores between BZD-dependent and non-BZD-dependent
groups showed no statistical difference (pZ 0.101). Scores
on the other four items were significantly different
(p< 0.001). For all questions, the AUCs ranged from 0.718
to 0.566, where Question 3 had the highest value andQuestion 4 the lowest value. The results are shown in
Table 3 and Fig. 1. The logistic regression was also con-
ducted to estimate adjusted odds ratios of BZD depen-
dence; analysis variables also included marital status,
comorbid diagnosis, and duration and types of BZD use. The
adjusted odds ratios were from 2.284 to 1.281 and the
detailed data are shown in Table 4.
The concurrent validity analyzed by Spearman’s
product-moment correlation coefficients between SDS[Ch]
total scores and the sum of the Diagnostic and Statistical
Manual of Mental DisordersdFourth Edition dependence
items ranged from 0.016 to 0.336. Construct validity
assessed by principal components analysis showed two
dimensions in which SDS[Ch] Questions 1e3 and 5 presented
in one dimension and SDS[Ch] Question 4 in the other. The
communalities of each SDS[Ch] question ranged from 0.58 to
0.81. Internal reliability using Chronbach’s alpha was 0.63.
When the MINI was used to classify these patients into BZD-
dependent and non-BZD-dependent groupsdand a score of
7 or higher on the SDS[Ch] screened for BZD depend-
encedthose patients with false diagnoses tended to be
Table 2 Cutoff points for SDS[Ch]
SDS[Ch] score True positive True negative False positive False negative Sensitivity 1 Specificity
15 5 143 3 77 0.0610 0.0205
14 6 143 3 76 0.0732 0.0205
13 6 139 7 76 0.0732 0.0479
12 14 138 8 68 0.1707 0.0548
11 24 134 12 58 0.2927 0.0822
10 33 129 17 49 0.4024 0.1164
9 38 119 27 44 0.4634 0.1849
8 54 108 38 28 0.6585 0.2603
7a 66 96 50 16 0.8049 0.3425
6 74 79 67 8 0.9024 0.4589
5 78 64 82 4 0.9512 0.5616
4 80 41 105 2 0.9756 0.7192
3 82 22 124 0 1.0000 0.8493
2 82 9 137 0 1.0000 0.9384
1 82 3 143 0 1.0000 0.9795
0 82 0 146 0 1.0000 1.0000
a The best cutoff point on the SDS[Ch]
SDS[Ch]Z Chinese version of the Severity of Dependence Scale.
228 J.-H. Tsai et al.jobless (pZ 0.023) and to have higher SDS[Ch] scores
(p< 0.001).Discussion
This study found that the incidence of BZD dependence
among our sample was 36%. Risk factors for developing BZD
dependence were marital status, comorbid diagnosis, and
duration and type of BZD use. In identifying BZD depen-
dence, a cutoff point of 7 or higher on the SDS[Ch] had a high
diagnostic utility (AUCZ 0.779), a sensitivity of 80.5%, and
a specificity of 85.7%. We also found that the SDS[Ch]
questions, except for Question 4, were key to the diagnosis
of clinical BZD dependence in Taiwan.
BZD hypnotics are the most widely prescribed medica-
tions for insomnia, but most prescribing physicians and
patients worry about the adverse effects of BZD depen-
dence. Most previous studies have indicated that theTable 3 Proportion of scores on the Chinese version of the Seve
and non-BZD-dependent users
Question Question content BZD
us
1 Did you think your use of tranquilizers
was out of control?
1
2 Did the prospect of missing a dose make
you anxious or worried?
1
3 Did you worry about your use of tranquilizers? 1
4 Did you wish you could stop? 1




BZDZ benzodiazepine; ROCZ receiver operating characteristic curvincidence of BZD dependence among chronic users is in the
range of 15e44% [12e15]. Risk factors for the development
of BZD dependence include advanced age, female gender,
use of multiple BZDs, high dosage, and a long duration of
use [9,12,15,23]. The present study showed that the inci-
dence of BZD dependence in Taiwan among regular users
for 3 months or longer was 36%. This was consistent with
the results of previous studies [12e15]. The use of multiple
BZDs and a long duration of use were also factors involved
in BZD dependence. BZD dependence was higher among
women than men, but the difference was not significant.
This was insufficiently consistent with previously reported
results [15]. A higher rate of BZD dependence was shown in
our middle-aged group, a younger group than that previ-
ously reported [15,23]. Our results were similar to those of
de las Cuevas et al. [9], and the characteristics of the study
sample might explain this. Our sample was composed
primarily of middle-aged patients, and the elderly group







.41 1.08 0.67 0.96 <0.001 0.707
.77 1.11 1.12 1.10 <0.001 0.659
.80 1.08 0.92 1.03 <0.001 0.718
.56 1.09 1.31 1.12 0.101 0.566
.28 0.79 1.62 0.98 <0.001 0.689
.83 2.82 5.64 3.24 <0.001 0.779
e.
Figure 1. Receiver operating characteristic curve and AUC
for various questions about benzodiazepine dependence on the
SDS[Ch]. AUCZ area under the ROC curve; SDS[Ch]Z Chinese
version of the Severity of Dependence Scale.
SDS[Ch] for BZD dependence in Taiwan 229Marital status affected the development of BZD depen-
dence in our study, which is different from the results of
most previous studies [9,12,15,23].
The SDS has been a reliable and valid questionnaire
when used to assess the degree of dependence on different
types of illicit drugs [17,18]. In one study, the SDS was used
to screen for BZD dependence among neurotic patients for
whom a Compositing International Diagnostic Interview 2.1
diagnosis of BZD dependence had been made. A cutoff
score of 7 or higher on the SDS had high diagnostic utility
(AUCZ 0.991), high sensitivity (97.9%), and high specificity
(94.2%) [18]. In our study, the SDS[Ch] diagnosis of BZD
dependence had the same high diagnostic utility as the SDS
and the same cutoff score [18]; however, our results for
AUC, sensitivity, and specificity were lower than the
previous results for the SDS [18]. There might be many
factors to affect these results, including diagnostic tools,Table 4 The adjusted odds ratios of benzodiazepine dependen
questions
Question Question content
1 Did you think your use of tranquilizers
was out of control?
2 Did the prospect of missing a dose make
you anxious or worried?
3 Did you worry about your use of tranquiliz
4 Did you wish you could stop?
5 How difficult would you find it to stop
or go without your tranquillizers?
Total
Adjusted with analysis variables also included marital status, comorb
CIZ confidence interval.clinical samples, comorbid diagnoses, cultural factors, and
so on. These different results might have been the result of
the criteria used to establish the diagnosis (MINI vs.
Compositing International Diagnostic Interview 2.1) and
characteristics of the clinical populations. Our patients
came from two outpatient mental health services in
a medical center and a regional hospital, whereas those in
another study came from only one neurotic service center
in the Canary Islands [18]. Our patients came from two
hospitals and also had more complicated comorbid diag-
noses. Cultural factors might have an effect on shape the
subjective distress that accompanies medication taking and
physiological dependence, which would, therefore, lead to
an elevated score on a subjective scale. Although we found
that both the sensitivity and specificity of the instrument
were lower than expected, the SDS[Ch] is still of diagnostic
utility among Taiwanese (Chinese) users.
On the analysis of the SDS[Ch] question items, the scores
on SDS[Ch] of Question 4 among BZD-dependent users were
not different from those of the non-BZD-dependent users.
This was obviously different from previous results [17e19]
and might have affected our AUC, sensitivity, and speci-
ficity data. This also implies that the SDS[Ch] questions,
except for Question 4, are key to the diagnosis of clinical
BZD dependence in Taiwan. On further analysis of other
factors affecting validity, our results indicated that false
diagnoses tended to be associated with joblessness and
higher SDS[Ch] scores. BZD users without a job might show
more drug-seeking behaviors. It is, therefore, important to
pay attention to special groups, especially jobless patients
with high SDS[Ch] scores, while using SDS[Ch] for broad
screening of BZD dependence among regular users.
This study has some limitations. First, the study pop-
ulation was representative only of outpatients attending
a medical center and a regional hospital. Further study is
needed in general or community populations. Second, our
study population was limited to BZD users. Further studies
are needed to determine whether the same cutoff point
can be used with abusers of other substances.
In conclusion, the incidence of dependence among this
Taiwanese sample of outpatients who used BZDs for 3




1.825 (1.307, 2.548) <0.001
1.874 (1.362, 2.577) <0.001
ers? 2.027 (1.469, 2.789) <0.001
1.281 (0.945, 1.735) 0.111
2.284 (1.524, 3.423) <0.001
1.383 (1.224, 1.563) <0.001
id diagnosis, and duration and type of benzodiazepine use.
230 J.-H. Tsai et al.users tended to be divorced or widowed; not schizophrenic;
and have higher SDS[Ch] scores, a longer duration of use, and
multiple-BZD use. The SDS[Ch] was shown to have a high
diagnostic utility with a cutoff point of 7 in identifying
problematic BZD users. It is, therefore, a valid brief self-
reported questionnaire for the assessment of BZD depen-
dence among regular BZD users in Taiwan.
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